Should the hepatitis C positive end stage renal disease patient be transplanted?

Seminars in Dialysis

Volumn 9, Issue 1, 1996, Pages 5-8

  Glicklich, Daniel ^a,b   Kapoian, Toros ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002617499     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1996.tb00889.x     Document Type: Article

References (45)

1. Kirkman RL, Strom TB, Weir MR, Tilney NRL: Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 34:347-351, 1982
2. Lefroncois N, Elmghabbar N, Chossegros P, Beutel H, Faure JL, Revillard JP, Traeger J, Duberhard JM, Torraine JL: Long term results in kidney transplantation: Patient and graft survival, causes of graft failure and mortality, renal function and complications after ten years. Transpl Proc 19:3767-3768, 1987
3. Rao KV, Anderson RC: Long-term results and complication in renal transplant recipients: observations in the second decade. Transplantation 45:45-52, 1988
4. Sengar DPS, Couture RA, Lazarovits AI: Long-term patient and renal allograft survival in HBsAg infection. Transpl Proc 21:3358-3359, 1989
5. First MR: Long-term complications after transplantation. Am J Kidney Dis 22:477-486, 1993
6. Caramelo C, Ortiz A, Aguilera B, Porres JC, Navas S, Marriott E, Alberola ML, Alamo C, Galera A, Garron MP, Gonzalez-Parra E, Fernandez de Gabriel MV, Oliva H, Carreno V: Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 22:822-828, 1993
7. Pol S, Romeo R, Zins B, Driss F, Lebkin B, Carnot F: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 44:1097-1100, 1993
8. Kuhns M, de Medina M, McNamara A, Jeffers LJ, Reddy KR, Silva M, Ortiz L, Jiminez M, Schiff ER: Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 4:1491-1497, 1994
9. Simon N, Courouce AM, Lemarreo N, Trepo C, Ducamp S: A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 46:504-511, 1994
10. Roth D: Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 25:3-16, 1995
11. Natov SN, Pereira BJG: Hepatitis C infection in patients on dialysis. Sem Dialysis 7:360-368, 1994
12. Pereira BJG, Milford EL, Kirkman RL, Sayre KR, Johnson PJ, Wilber JL, Quan S, Levey AS: Prevalence of HCV RNA in hepatitis antibody positive cadaveric organ donors and their recipients. N Engl J Med 327:910-915, 1992
13. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH: High prevalence of hepatitis C virus RNA in dialysis patients: Significant number of patients with HCV infection. J Infect Dis 168: 1343-1348, 1993
14. Chan T, Lok ASF, Chen IKP, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104:862-868, 1993
15. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu Py, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905, 1992
16. Goffin E, Pirson Y, Cornu C, Gerbel A, Squifflet JP, Van Ypersele de Strihou C: Outcome of HCV infection after renal transplantation. Kidney Int 45:551-555, 1994
17. Meshari KA, Shaibani KA, Alfurayh O, Qunibi WY, Ali MA: Kidney Transplantation in HCV infected hemodialysis patients with mild hepatitis: a prospective controlled study of liver disease and graft function. J Am Soc Nephrol 5:993, 1994
18. Strauss RM, Gitlin N, Caudill M, Neylan JF, Nolte FS, Whelchel JD, Boyer TD: Chronic hepatitis C: A contraindication to renal transplantation? Hepatology 18:344A, 1993
19. Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J: The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 45:238-244, 1994
20. Dubois DB, Gretch D, del Rosa C, Lee W, Fine J, Blagg CR, Corey L: Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: Gender-related differences in viral load. Am J Kidney Dis 24: 795-801, 1994
21. Glicklich D, Reinus J, Greenstein S, Schechner R, Mallis M, Clemetson S, Tellis V: Hepatitis C infection in renal transplant recipients: Histology and clinical features. J Am Soc Nephrol 5:1007, 1994
22. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshikawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelations of blood transfusion, non-A non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
23. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated Hepatitis C. N Engl J Med 332:1463-1466, 1995
24. Stempel CA, Lake J, Kuo G, Vincenti F: Hepatitis C - its prevalence in end-stage renal failure patients and clinical course after kidney-transplantation. Transplantation 55:273-276, 1993
25. Pol S, Legendre C, Saltiel C, Carnot F, Brechot C, Berthelot P, Mattlinger B, Kreis H: Hepatitis C virus in kidney recipients: Epidemiology and impact on renal transplantation. J Hepatol 15:202-206, 1992
26. Pol S: Hepatitis C virus infection in hemodialyzed patients and kidney allograft recipients. Advances in Nephrology 24:315-330, 1995
27. Pereira BJG, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis c virus by organ transplantation. N Engl J Med 325:454-460, 1991
28. Alfurayh O, Sobh M, Buali AR, Ali MA, Barri Y, Qunibi W, Taher S: Hepatitis C infection in chronic hemodialysis patients, a clinicopathologic study. Nephrol Dial Transplant 7:327-332, 1992
29. Casanovas-Taltavull T, Baliellas C, Fernandez-Esparrach G, Rota R, Casas R, Benasco C, Grino JM, Andres E, Casais L: Liver biopsy in hemodialysis patients with chronic hepatitis C virus infection: A prospective study to determine the impact of liver injury severity on patients outcome. Hepatology 18:326A, 1993
30. Nieto J, Ferreras I, Mora F, Caparros G, Sanchez A, de la Torre M, Peces R: Liver histopathological findings in hemodialysis patients with chronic hepatitis C virus infection. Nephrol Dial Transplant 8: 971, 1993
31. Ozyilkan E, Akpolat T, Arik N, Koseoglo HT, Telatar H: Characteristics of chronic hepatitis C virus infection in patients on maintenance hemodialysis. Nephrol Dial Transplant 9:1697-1698 1994
32. Morales JM, Dominques P, Colina F, Lopez Carreira M, Castellano G, Fuertes A, Andres A, Fernandez G, Rodicio JL: Peculiarity of histological liver disease in hepatitis C infected kidney transplanted patients. J Am Soc Nephrol 5:1025, 1994
33. Morales JM, Munoz MA, Castellano G, Colina F, Fuertes A, Andres A, Campo C, Blasco A, Hernandez E, Rodicio JL: Impact of hepatitis C in long-functioning renal transplants - a clinicopathological follow up. Transplant Proc 25:1450-1453, 1993
34. Chan TM, Wu PC, Lau JYN, Lai CL, Lok ASF, Cheng IKP: Clinicopathologic features of hepatitis C virus infection in renal allograft recipients. Transplantation 58:996-1000, 1994
35. Rao KV, Anderson WR, Kasiske BL: Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients. Am J Med 94:241-250, 1993
36. Simmonds P: Variability of Hepatitis C virus. Hepatology 21:570-583, 1995
37. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized controlled trial. N Engl J Med 321:1501-1506, 1989
38. Ohnishi K, Nomura F, Nakano M: Interferon therapy for acute post-transfusion non-A, non-B hepatitis: Response with respect to antihepatitis C virus antibody status. Am J Gastroenterol 86:1041-1049, 1991
39. Koenig P, Vogel W, UmLauft F, Weyrer K, Prommeggar R, Lhotta K, Neyer N, Stumavoll HK, Grunewald K: Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 45: 1507-1509, 1994
40. Rao VK, Anderson WR: Effectiveness of alpha interferon treatment in altering the clinical and histological course of chronic viral hepatitis of ESRD patients awaiting renal transplantation. J Am Soc Nephrol 5:1032, 1994
41. Cerini R, Cozzolino G, Morante R, Lucariello A, De Rosa ML, Cacciatore F: Relatively high dose for twelve months recombinant leukocyte interferon-alpha treatment in chronic hepatitis: A randomized controlled study. Hepatology 14:70A, 1991
42. Kovarik J, Mayer G, Pohanka E, Schwartz M, Traindl O, Graf H, Smolen J: Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Transplantation 45:402-405, 1988
43. Kramer P, Ten Kate FWJ, Bijnen AB, Jeekel J, Weimer W: Recombinant leukocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1:989-990, 1984
44. Rostaing L, Baron E, Modesto A, Girolami JP, Durand D, Suc JM: Renal failure in renal transplant patients treated with interferon A for chronic hepatitis C. J Am Soc Nephrol 5:1034, 1994
45. Rhodes J, Jones DH, Bleeher NM: Increased expression of human monocyte HLA-DR antigens and Fc receptors in response to human interferon in vivo. Clin Exp Immunol 53:739-744, 1983